By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals targeting a novel form of…
Elon Musk says Twitter’s cash flow still negative as ad revenue drops 50%
By Jahnavi Nidumolu and Krystal Hu (Reuters) -Twitter’s cash flow remains negative because of a nearly 50% drop in advertising…
Bill Ackman Believes an Unlikely Candidate Will Be President
Bill Ackman, the mastermind behind Pershing Square, has made an audacious forecast for the 2024 Republican primary race, foreseeing…
A Storm is Brewing: Ex-Goldman Hotshot
Ex-Goldman Sachs Group Inc (NYSE:GS) hedge fund hotshot, Raoul Pal, is sounding the alarm bells. According to him, a…
Amazon/Shopify Partnership in the Works?
In a recent discussion as part of the Amazon Advisor Call Series, Scott Devitt, an analyst at Wedbush, and…
Traders: Pessimism Brewing for Ford
A moneyed titan appears to be going all-in on a pessimistic bet against Ford Motor (NYSE:F), an occurrence that…
What challenges does Microsoft’s $69 billion Activision deal face?
(This story has been refiled to fix the dateline) By Foo Yun Chee and Chavi Mehta (Reuters) – The U.S.…
High-Yield Dividend Stocks Endorsed by Top Analysts
During times of market turbulence and uncertainty, many investors turn to dividend-yielding stocks. These are often companies with strong…
Major Investment Activity in Shell Sparks Interest Among Traders
A significant player with considerable resources has recently taken a bullish position on Shell (NYSE:SHEL), which is crucial information for…
Inflation Data Dominates Global Economy Says Mohamed El-Erian
In the coming week, the economic calendar will be dominated by key price data releases and Federal Reserve speeches,…